International Edition
Latest News
Health

Vitamin B12 Reverses Verheij Syndrome Defects in Worms

“We were surprised to find that a change in a fundamental process of RNA processing had such a targeted effect on vitamin B12-dependent metabolism,” Jonathan Kölschbach said, ScienceDaily reported. Researchers discovered that vitamin B12 can correct developmental problems…

Vitamin B12 Reverses Verheij Syndrome Defects in Worms

“We were surprised to find that a change in a fundamental process of RNA processing had such a targeted effect on vitamin B12-dependent metabolism,” Jonathan Kölschbach said, ScienceDaily reported.

Researchers discovered that vitamin B12 can correct developmental problems in tiny roundworms carrying a genetic mutation associated with Verheij syndrome. The rare human condition causes developmental delays, impaired growth, and short stature.

Scientists investigated how a related mutation affects growth and metabolism in a laboratory model. The discoveries focus on a mechanism within cells known as RNA splicing, which assists in getting genetic instructions ready for protein production.

The splicing procedure eliminates unwanted parts of messenger RNA and links the remaining segments together sequentially. When this process goes wrong, it disrupts essential cellular functions and contributes to serious developmental disorders. Mutations in genes responsible for splicing cause conditions such as Verheij syndrome.

The discovery emerged from experiments involving C. elegans, a tiny roundworm commonly used in biological research. Investigators were hunting for novel genes affecting longevity when they started looking at a mutation within a gene linked to RNA splicing. The same gene is associated with Verheij syndrome in humans, ScienceDaily reported.

Worms carrying the mutation developed problems resembling important features of the human disorder. Their growth slowed considerably, and they remained smaller than normal.

To investigate why this happened, scientists conducted genetic screens and analyzed the worms’ metabolism. Their analysis revealed that the mutation impaired particular metabolic networks reliant on vitamin B12, which are crucial for normal cellular function and healthy growth.

The researchers then tested whether providing additional vitamin B12 could counteract these changes. Supplementation successfully brought the disrupted metabolic pathways back to a healthy state and fixed the developmental defects caused by the mutation.

“Even more exciting was that we were able to largely correct the consequences of this change in the worm model using vitamin B12,” Kölschbach, first author of the study, told ScienceDaily.

To explore whether findings might apply to people, researchers examined publicly available datasets from human cells. Furthermore, they collaborated with Hormos Dafsari—a neuropediatrician based at the University Hospital Cologne—to gather blood specimens from individuals with a Verheij syndrome diagnosis.

These investigations uncovered evidence of similar metabolic changes in humans. The findings suggest that the vitamin B12-related pathways affected in worms may also play a role in the human disorder.

Researchers have not yet established whether vitamin B12 supplementation can improve symptoms in people with Verheij syndrome. Additional studies are necessary to determine whether benefits observed in worms can be translated into a treatment for patients.

The discovery raises a broader possibility that metabolic disruptions may contribute more substantially to diseases caused by faulty RNA splicing than scientists previously recognized.

Grasping these links might enable scientists to develop novel medical treatments, with prospective applications reaching past Verheij syndrome to include other uncommon genetic disorders.

“Our study is a good example of how basic research on model organisms can provide new insights into human diseases,” said Adam Antebi, lead author of the study.

“A fundamental biological question can thus give rise to a new approach that could also become medically relevant in the long term,” Antebi told ScienceDaily.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”